Dengue virus capsid interacts with DDX3X-a potential mechanism for suppression of antiviral functions in dengue infection by Kumar, Rinki et al.
ORIGINAL RESEARCH
published: 17 January 2018
doi: 10.3389/fcimb.2017.00542
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 1 January 2018 | Volume 7 | Article 542
Edited by:
James Drew Brien,
Saint Louis University, United States
Reviewed by:
Penghua Wang,
New York Medical College,
United States
Sunnie R. Thompson,
University of Alabama at Birmingham,
United States
Tonya Michelle Colpitts,






Received: 18 August 2017
Accepted: 26 December 2017
Published: 17 January 2018
Citation:
Kumar R, Singh N, Abdin MZ,
Patel AH and Medigeshi GR (2018)
Dengue Virus Capsid Interacts with
DDX3X–A Potential Mechanism for
Suppression of Antiviral Functions in
Dengue Infection.
Front. Cell. Infect. Microbiol. 7:542.
doi: 10.3389/fcimb.2017.00542
Dengue Virus Capsid Interacts with
DDX3X–A Potential Mechanism for
Suppression of Antiviral Functions in
Dengue Infection
Rinki Kumar 1, 2, Nirpendra Singh 3, Malik Z. Abdin 2, Arvind H. Patel 4 and
Guruprasad R. Medigeshi 1*
1Clinical and Cellular Virology Lab, Vaccine and Infectious Disease Research Center, Translational Health Science and
Technology Institute, NCR-Biotech Science Cluster, Faridabad, India, 2Department of Biotechnology, Jamia Hamdard,
New Delhi, India, 3 Regional Center for Biotechnology, NCR-Biotech Science Cluster, Faridabad, India, 4MRC-University of
Glasgow Centre for Virus Research, Glasgow, United Kingdom
Dengue virus is a pathogen of global concern and has a huge impact on public health
system in low- and middle-income countries. The capsid protein of dengue virus is
least conserved among related flavivirus and there is very limited information on the
role of cytosolic proteins that interact with dengue virus capsid. We identified DEAD
(Asp-Glu-Ala-Asp) Box Helicase 3, an X-Linked (DDX3X), cytosolic ATP-dependent RNA
helicase as a dengue virus capsid-interacting protein. We show that the N-terminal region
of capsid is important for interaction with DDX3X, while the N-terminal domain of DDX3X
seems to be involved in interaction with dengue capsid. DDX3X was down-regulated in
dengue virus infected cells at later stages of infection. Our results show that DDX3X is
an antiviral protein as suppression of DDX3X expression by siRNA led to an increase in
viral titers and overexpression of DDX3X led to inhibition of viral replication. Knock-down
of DDX3X did not affect induction of type I interferon response upon infection suggesting
that the effect of DDX3X knock-down is independent of the interferon-dependent
pathways that DDX3X modulates under normal conditions. Thus, our study identifies
DDX3X as a dengue virus capsid interacting protein and indicates a potential link between
the antiviral functions of DDX3X and dengue capsid at later stages of dengue infection.
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INTRODUCTION
Dengue is the most common mosquito-borne viral disease in tropical and subtropical areas,
with an estimated 50–100 million infections occurring each year. Dengue virus (DENV) is
a member of Flaviviridae family, which consists of a group of enveloped, positive sense,
single-stranded, RNA viruses. DENV genome encodes three structural proteins, namely core
(C), membrane (prM/M), and envelope (E), and seven non-structural proteins, (NS1, NS2A,
NS2B, NS3, NS4A, NS4B, and NS5), which are produced via proteolytic processing of the
single polyprotein by viral serine protease (NS2B-NS3) and cellular proteases (Medigeshi, 2011).
Sequential cleavages of the anchored capsid protein by viral protease and host signalase result
in removal of the C-terminal trans-membrane region to yield the 100-residue mature form,
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which is a highly basic 12 kDa protein (Amberg et al., 1994;
Yamshchikov and Compans, 1995; Sangiambut et al., 2008, 2013).
While the mechanism by which encapsidation occurs is not
completely understood, it is proposed that the capsid protein
interacts with the viral genome to form the nucleocapsid, possibly
via interactions with basic surfaces on the solvent-exposed side
of the protein (Jones et al., 2003; Ma et al., 2004). A number of
host proteins have been identified as capsid-interacting proteins
for various flaviviruses and these studies implicate capsid in a
variety of functions such as lipid metabolism, apoptosis and
stress granule formation (Byk and Gamarnik, 2016). West Nile
virus capsid protein has been proposed to activate pro-survival
pathways by blocking apoptosis through a phosphatidylinositol
(PI) 3-kinase-dependent pathway (Urbanowski and Hobman,
2013). However, another study showed an opposite role for
capsid where, WNV capsid was shown to induce apoptosis in
a p53-dependent manner (Yang et al., 2008). Recent studies
have also proposed a role for JEV capsid protein in blocking
stress granule formation and relieving translation repression by
interaction with Caprin-1 (Katoh et al., 2013). DENV capsid
was shown to colocalize with MX1/MxA, an interferon-induced
GTPase involved in antiviral signaling in primary endothelial
cells infected with DENV-2 suggesting a role for capsid protien
in blocking antiviral pathways (Kanlaya et al., 2010).
Many groups have identified capsid-interacting proteins some
of which include nucleolin, histone proteins H2A, H2B, H3, H4,
and importin-α (Bhuvanakantham et al., 2009; Netsawang et al.,
2010; Colpitts et al., 2011; Balinsky et al., 2013; Bhuvanakantham
and Ng, 2013; Mairiang et al., 2013). Overexpression of
capsid protein leads to nuclear localization, therefore, it is
not surprising, that most of the capsid-interacting proteins
identified above are nuclear proteins. Although the C protein
of dengue virus localizes to the nucleus of mammalian cells
and remains at high levels throughout the course of infection
(Wang et al., 2002; Sangiambut et al., 2008), its role in the
nucleus is not yet understood. Given the role of C in promoting
encapsidation of the viral RNA and subsequent assembly of
infectious virus particles, it is imperative to identify non-nuclear
capsid-interacting proteins to further elucidate the role of capsid
in dengue virus life-cycle. In this study, we adopted an in-solution
interaction approach and identified 16 proteins interacting
with DENV capsid by proteomics and mass spectrometry.
One of the capsid-interacting proteins identified was DDX3X,
a DEAD (Asp-Glu-Ala-Asp)-box helicase. DEAD-box RNA
helicases belong to helicase superfamily 2 and consist of two
large domains, the N- terminal and C-terminal domains which
consist of 9 conserved sequence motifs (Garbelli et al., 2011b).
DDX3X shuttles between cytoplasm and the nucleus and plays
a multifunctional role such as RNA splicing, transcriptional and
translational regulation, mRNA export and translation initiation,
and it also contributes to the nuclear export of RNA (Owsianka
and Patel, 1999; Yedavalli et al., 2004; Lai et al., 2008; Schroder,
2011). DDX3X has also been shown to regulate innate immune
responses through its interaction with components of antiviral
signaling such as mitochondrial antiviral signaling protein,
TANK-binding kinase-1 and I-kappa-B kinase epsilon which
results in IRF3 and IRF7 activation and interferon-β production
(Schröder et al., 2008; Soulat et al., 2008; Mulhern and Bowie,
2010; Oshiumi et al., 2010b). Recent reports suggests that many
viruses usurp the function of DDX3X to promote viral RNA
replication or prevent DDX3X functions (Valiente-Echeverría
et al., 2015). Therefore, we further characterized the role of
DDX3X in dengue infection as a capsid-interacting partner. We
show that DDX3X is an antiviral protein and interaction of
DENV capsid with DDX3X may counter the antagonistic effect
of DDX3X in DENV life-cycle.
MATERIALS AND METHODS
Cells and Viruses
All the cell lines, virus strain used in this study and virus titering
protocols have been described previously (Agrawal et al., 2013;
Medigeshi et al., 2016). Huh-7, HEK293T, A549 cells were grown
in Dulbecco’s modified Eagle medium (DMEM) supplemented
with 10% fetal bovine serum (FBS), 1mM L-glutamine, 100
units/ml penicillin-streptomycin-glutamine and non-essential
amino acids at 37◦C and 5% CO2. BHK-21 and C6/36 cells
were grown in the minimal essential medium (MEM) containing
10% FBS, Earl’s salts and PSG in the concentration mentioned
above. Dengue virus serotype 2 obtained from National Institute
of virology, India (Dengue virus 2 isolate P23085 INDI-60-
GenBank: KJ918750.1) was used throughout the study. The virus
was cultured in C6/36 cell lines and titered by plaque assay in
BHK21 cells as described previously (Agrawal et al., 2013).
Antibodies
Mouse monoclonal antibodies for anti-6X his-tag (Abcam -
ab18184) (1:1,000), HA (Biolegend 901501) (1:1,000), α-tubulin
(Clone 12G10 from Developmental Studies Hybridoma Bank,
University of Iowa) (1:5,000) and viral envelope (Merck-
Millipore MAB10216) (1:1,000) were used. Rabbit polyclonal
antibodies for GAPDH (1:5,000) were from Cell Signaling
Technology (CST 2118). Rabbit polyclonal dengue-capsid
antibody was used for immunoblotting (1:1,000) (Agrawal et al.,
2013). Rabbit polyclonal DDX3X (R648) antibody (1:2,000 for
western blotting and 1:1,000 for immunofluorescence) has been
described before (Angus et al., 2010). Anti-rabbit (Merck-
Millipore) or anti-mouse (Sigma) IgG secondary antibodies
raised in goat and conjugated with horseradish peroxidase (HRP)
(1:2,000) were used. HRP-conjugated secondary antibodies
specific to IgG-light chain (Jackson’s Immunoresearch Lab) were
used (1:10,000) for probing blots of immunoprecipitation.
Cloning, Expression, and Purification of
DENV2 Capsid
DENV2 full-length capsid construct was generated by PCR and
cloning into pET-23b vector using the forward primer 5′-TAC
ATATGAATAACCAACGGAAAAAGG-3′ and reverse primer
5′-GACTCGAGTCTGCGTCTCCTGTTCAAG-3′ using NdeI &
XhoI sites. Capsid clone in a mammalian expression vector
pEF1/mychisC was generated using the forward primer 5′-TAGG
TACCATGAATAACCAACGGAAAAAG-3′ and reverse primer
5′-TAGCGGCCGCTCAGTGGTGGTGGTGGTG-3′ with KpnI
and NotI restriction sites.
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Capsid deletion constructs were generated in pEF1/mychisA
with KpnI & NotI sites using the following primers: α2-4-capsid
(26-100 a.a) 5′-TAGGTACCATGAAACTGTTCATGGCCC-3′
(forward) and 5′-TAGCGGCCGCTCAGTGGTGGTGGTGGT
G-3′ (reverse). α3-4-capsid (63–100 a.a) 5′-TAGGTACCATGG
CAGGGATATTGAAGA-3′(forward) and 5′ TAGCGGCCGCT
CAGTGGTGGTGGTGGTG-3′ (reverse). α4-capsid (74–100 a.a)
5′-TAGGTACCATGAAATCAAAAGC-3′ (forward) and 5′-TAG
CGGCCGCTCAGTGGTGGTGGTGGTG-3′ (reverse). Plasmids
were constructed by standard PCR methods using Expand
Hi fidelityplus PCR system (Roche). Clones were verified by
sequencing.
Protein Purification
The His-tagged full length DENV2 capsid clone was generated
in pET23b vector as described above, and expressed in
BL21DE3pLysS cells for protein purification as per standard
procedures. Briefly, an overnight culture of pET23b-capsid
was inoculated into fresh Luria-Bertani (LB) media containing
ampicillin and chloramphenicol. At an O.D600 of 0.4–0.5, protein
expression was induced using isopropyl-beta-D-thiogalactoside
(IPTG) to a final concentration of 1mM for 4 h at 37◦C. Cells
were harvested by centrifugation at 4,000 × g for 20min. Cell
pellet was resuspended in cold lysis buffer (50mM NaH2PO4,
150mM NaCl, and phenylmethanesulfonylfluoride (PMSF), pH
8.0) followed by sonication. All steps were carried out at 4◦C.
The crude extract was centrifuged at 17,000 × g. Triton-X-100
and imidazole was added to a final concentration of 1% and
20mM respectively. Lysate was incubated with pre-washed Ni-
NTA beads (Qiagen) for 2 h. The beads were washed three times
with wash buffer (50mM NaH2PO4, 150mM NaCl, 1% Triton-
X-100, 50mM imidazole, pH 8.0). Capsid protein was eluted
using 100, 250, and 500mM imidazole buffer pH 8.0. The purified
capsid protein was dialyzed overnight using a dialysis cassette
with a cut-off value of 2 kDa (ThermoFisher Scientific) in dialysis
buffer (50mM NaH2PO4, 150mM NaCl, 20mM imidazole and
0.1% triton).
Interaction Studies
Huh-7 (human hepatocyte) cells from a confluent T150 flask
were used for each interaction experiment. The cells were
lysed in cold lysis buffer (50mM NaH2PO4, 150mM NaCl,
0.1% Triton-X-100, protease inhibitor cocktail (PIC), sodium
orthovanadate and PMSF). The lysate was centrifuged at 17,000
× g at 4◦C and supernatant was collected. 5mg of the Huh-7
lysate protein was incubated with pre-washed Ni-NTA beads for
1 h as a pre-clearing step. 2mg of dialyzed His-capsid protein
was added to the pre-cleared Huh-7 lysate and incubated at
4◦C for 2 h with continuous mixing. Prewashed Ni-NTA slurry
was added to the lysate mixture and further incubated for 1 h
at 4◦C. The beads were washed with buffer containing (50mM
NaH2PO4, 150mMNaCl, 0.1% Triton-X-100, 50mM imidazole)
and protein was eluted using 100 and 250mM imidazole elution
buffers. The eluates were precipitated overnight at 4◦C using 10%
trichloroacetic acid (TCA). Protein pellet was washed with 2%
sodium acetate in ethanol, air-dried, and resuspended in 8M urea
buffer (UB).
Filter-Aided Sample Processing (FASP) for
Mass Spectrometry
The TCA precipitated protein sample was resuspended in 200
µl of 8M UB, loaded in a 3 kDa filter unit (Amicon-Millipore)
and centrifuged at 14,000 × g for 15min. Sample was washed by
adding 200 µl of UB and centrifuged at 14,000 × g for 15min.
100µl of 0.05M iodoacetamide (IAA) prepared in UB was added
and mixed at 600 rpm for 1min and incubated without mixing
for 20min. This was followed by centrifugation at 14,000 × g
for 10min. Washing was done twice by adding 100 µl of UB
and centrifugation at 14,000 × g for 15min. This was followed
by two washes with 100 µl of 0.05M ammonium bicarbonate
(ABC) and centrifuged at 14,000× g for 10min. 40 µl ABC with
trypsin (Promega V511A) (enzyme to protein ratio 1:100) was
added and mixed at 600 rpm for 1min, and then incubated in a
water bath at 37◦C for 16–18 h. The digested peptides were eluted
at 14,000 × g for 10min. Any remaining peptides were eluted
with another 20–30 µl of ABC. The eluted sample was acidified
with 0.1% formic acid and concentrated to 10µl by speed vac. LC
MS/MSwas done using AB SCIEXTriple TOF 5600. The peptides
were identified by searching the MS data against the MASCOT
and PARAGON search engines. Proteins were selected for further
study based on a 5% false-discovery rate cut-off and a minimum
of 2-peptide-per-protein.
Cloning of DDX3X Plasmid Constructs
HA-DDX3X was a gift from Robin Reed (Addgene plasmid
# 44975). All plasmid constructs of DDX3X were generated
in pSELECT-CHA-zeo and pSELECT-cGFP-Blas with Age-
I & Bam-HI sites using the following primers: DDX3X-
full length (FL) was generated using 5′-TAACCGGTATG
AGTCATGTGGCAGTG-3′ (forward) and 5′-ATGGATCCGT
TACCCCACCAGTCAA-3′ (reverse). DDX3X-1351-661 was
generated using primers 5′-TAACCGGTATGAGTCATGTGG
CAGTG-3′ (forward) and 5′-GGATCCATCAGCTTCATCTA
A-3′ (reverse). DDX3X-1385-661 was generated using 5′-
TAACCGGT ATGAGTCATGTGGCAGTG-3′ (forward) and
5′GGATCCAGTAGCACTAAACATCAT3′ reverse). DDX3X-
11-2221351-661 was generated using 5′-TAACCGGTATGTGT
GCCCAAACAGGG-3′ (forward) 5′-GGATCCATATCCAACA
TCCGATC-3′ (reverse). DDX3X-11-381 was generated using 5′-
TAACCGGTATGGCTACTTTTCCTAAG-3′ (forward) 5′ATG
GATCCGTTACCCCACCAGTCAA3′ (reverse). Plasmids were
constructed by standard PCR methods using Expand Hi
fidelityplus PCR system (Roche). Clones were verified by
sequencing.
Immunoprecipitation (IP)
For transient transfection experiments, His-tagged capsid
and HA-DDX3X plasmid constructs were co-transfected in
HEK293T cells using Lipofectamine-2000 (Invitrogen). 24 h
post-transfection, cell lysates were prepared in cold lysis buffer
(0.5% Triton-X-100 in PBS containing PIC and PMSF). The
lysates were pre-cleared using protein A sepharose beads (GE
healthcare) and rabbit IgG for 1 h at 4◦C on a tube rotator. The
supernatant was collected and incubated with capsid antibody
overnight on a rotator at 4◦C. Next day, pre-washed protein A
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sepharose beads were added and incubated for 2 h. The beads
were washed with cold lysis buffer three times, and once with
cold PBS. The beads were boiled in Laemmli buffer at 95◦C for
5min, loaded on SDS PAGE and transferred to PVDFmembrane.
Blots were probed with capsid and HA antibody. IgG light chain-
specific secondary-HRP antibody was used to probe the blots.
For DENV infection experiments, Huh-7 cells were plated in
3 cm dishes and infected with DENV at 5 MOI. At 24 h pi cells
were collected in cold lysis buffer (0.5% Triton-X-100 in 1X TBS
containing PIC, PMSF and sodium orthovanadate). The lysates
were processed as described above and immunoprecipitation
was performed using Capsid or DDX3X antibody. For RNAse
treatment of lysates, infected Huh-7 cell lysates were treated with
200µg/ml of bovine pancreatic RNAse A for 2 h at 4◦C as per
previous reports (Höck et al., 2007). The untreated and treated
lysates were then used for pre-clearing with protein A sepharose
beads followed by immunoprecipitation with DDX3X antibody
as described above.
Pull-Down of HA-DDX3X using His-Capsid
HA-DDX3X deletion constructs were transfected into HEK293T
cells. 24 h p.t, cell lysates were prepared in cold lysis buffer (0.5%
Triton-X-100, 20mM Tris-Cl and 150mM NaCl, PIC, PMSF,
and sodium orthovanadate). Purified capsid protein (20 µg) was
added to the 80 µg of lysate (equivalent amount of all HA-tagged
protein normalized to expression levels) and incubated for 2 h
at 4◦C. Then 20mM imidazole and pre-washed Ni-NTA slurry
were added and incubated for 1 h at 4◦C with constant mixing.
The beads were washed with buffer containing 20mM Tris-
Cl,150mMNaCl and 20mM imidazole and boiled in 1X Laemmli
buffer and processed for western blot analysis with anti-HA and
capsid antibodies.
Western Blotting, siRNA Transfection, Real
Time PCR, and Immunofluorescence
Cell lysates were prepared and processed for western blot analysis
as described previously (Agrawal et al., 2013). siRNA targeting
the human DDX3X were purchased from Dharmacon (Cat. No.
L-006874-02, J-006874-07, and J-006874-18) and transfections
were performed as described previously (Kumar et al., 2016).
Total RNA isolation and real-time PCR conditions for DENV
viral RNA levels has been described before (Agrawal et al.,
2013; Kumar et al., 2016). Briefly, total RNA was isolated using
Trizol reagent (Life Technologies). cDNA was synthesized
using gDNA eraser Takara cDNA synthesis kit. qRT-PCR
was performed by one-step or two-step methods using either
Taqman or SYBR green chemistry. Two hundred nanogram of
total RNA was used to determine viral genome copy numbers
using Taqman one-step qRT-PCR using primers and probe for
DEN-UTR and normalized to GAPDH. DDX3X knock-down
levels were verified by SYBR green chemistry using the following
primers: Forward 5′ GGAGGAAGTACAGCCAGCAAAG
3′ and reverse 5′ CTGCCAATGCCATCGTAATCACTC 3′.
Immunofluorescence was performed by fixing cells with
methanol as described previously (Haridas et al., 2013) and
stained with DDX3X, dengue envelope protein and HA antibody.
Interferon beta mRNA was using the following forward and
reverse primers: 5′-AAACTCATGAGCAGTCTGCA-3′ and
5′-AGGAGATCTTCAGTTTCGGAGG-3′ (Jaworska et al.,
2007).
Cell Proliferation Assay
Cell proliferation was assessed using Promega’s CellTiter 96 R©
AQueous One Solution cell proliferation assay kit as per the
manufacturer’s protocol. Briefly, knockdown of DDX3X was
performed in Huh-7 cells using smart-pool siRNAs (si-DDX3X)
and single siRNA (si-DDX3X-1) in 96 well plate. At 48 h p.t cells,
20 µl of the AQueous One Solution was added to each well
containing 100 µl of media and incubated for 3 h. The reaction
was stopped by adding 25 µl of 10% SDS. The supernatant was
diluted 1:5 in PBS and absorbance was measured at 490 nm.
OD490 from media alone with the AQueous One Solution was
used to subtract background.
Flow Cytometry
Cells were collected by trypsinization and washed with FACS
buffer (PBS+0.25% FBS). The fixable viability stain (BD EF-
780) was added at 1:1,000 dilution and cells were incubated
at RT for 10min followed by washing with FACS buffer. Cells
were centrifuged at 700 × g for 5min and fixed in 3% PFA for
10min on ice. Subsequently all steps were carried out at 4◦C.
Cells were washed once with FACS buffer and permeabilized with
IMF buffer (20mM HEPES pH 7.5, 0.1% triton-X 100, 150mM
NaCl, 5mM EDTA, 0.02% sodium azide) for 20min. The cells
were washed with FACS buffer and pelleted by centrifugation.
Primary anti-dengue envelope antibody conjugated to APC was
prepared in IMF buffer at a dilution of 1:400, added to the cells
and incubated for 1 h. The cells were washed twice with FACS
buffer and resuspended in 1X PBS and acquired in BD FACS
Canto-II. 50,000 cells were acquired in forward vs. side scatter
in a linear scale. Data was analyzed using FlowJo (Treestar).
Statistical Analysis
GraphPad Prism software was used for all graphical
representations and statistical analysis. All experiments
were performed with two or three technical triplicates and all
experiments have been performed two or more times. Non
parametric, two tailed t-tests were performed to calculate
p-values. ∗p< 0.05, ∗∗p< 0.005, and ∗∗∗p< 0.0005.
RESULTS
Identification of DDX3X as a DENV
Capsid-Interacting Protein
Previous studies have identified a number of cellular proteins
that interact with dengue capsid using yeast-two-hybrid system
and co-immunoprecipitation studies (Limjindaporn et al., 2007;
Netsawang et al., 2010; Balinsky et al., 2013; Mairiang et al.,
2013). Interestingly, these studies focused on the nuclear
proteins that bound to capsid and elucidated the mechanism of
capsid transport to the nucleus and possible link of host gene
regulation due to the interaction of host proteins with capsid
(Bhuvanakantham et al., 2009; Balinsky et al., 2013). To identify
cytosolic proteins that interact with DENV capsid, we expressed
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and purifiedDENV capsid protein without themembrane anchor
domain in a bacterial expression system (Figure S1). The purified
His-tagged capsid protein was allowed to interact in-solution
with cell lysates prepared from Huh-7 cells. Ni-NTA beads were
added to the reaction mix to pull down the capsid and any other
interacting proteins. As capsid protein expressed in bacteria lacks
post-translational modifications compared to the capsid protein
in mammalian cells, it is likely that many interacting partners
whose interaction depends on post-translational modifications
would be missed by our approach. Nevertheless, the proteins
bound to the beads were eluted and were digested with trypsin
and processed for LCMS/MS to identify interacting proteins. The
identification of peptides was performed by searching the Mascot
and Paragon search engines and proteins were selected with a
5% false-discovery rate cut-off and a minimum of 2-peptide-
per-protein. Using these criteria, 16 proteins were identified as
potential DENV capsid interacting proteins (Table 1). Of these,
DDX3X, which was identified consistently in four experiments,
with the highest number of peptides was selected for further
characterization.
Domain Mapping of DENV Capsid and
DDX3X Interaction
We validated the mass spectrometry data by confirming the
pull-down of DDX3X in the eluates from capsid and Huh-
7 lysate interaction experiment by western blot analysis and
identifiedDDX3X in interactions that had both the capsid protein
and cell lysates but not with beads that were incubated with
Huh-7 cell lysate without capsid (Figure 1A). We next used
HEK293T cells for co-transfection of His-capsid andHA-DDX3X
TABLE 1 | List of identified potential capsid interacting proteins from mass
spectrometry analysis.
Identified protein No. of peptides
(95% confidence)
DDX3X: DEAD (Asp-Glu-Ala-Asp) box, X-Linked, ATP
dependent RNA helicase 3
25
Heterogeneous nuclear ribonucleoprotein Q 13
cDNA FLJ54373, highly similar to 60 kDa heat shock protein,
mitochondrial
9
60S ribosomal protein L35 7
Heterogeneous nuclear ribonucleoprotein A0 6
Heterogeneous nuclear ribonucleoprotein A1 6
Histone H1.4 6
Heterogeneous nuclear ribonucleoprotein U 4
40S ribosomal protein S13 3
40S ribosomal protein S11 3
40S ribosomal protein S15a 2
40S ribosomal protein S8 2
60S ribosomal protein L23a 2
Pyrroline-5-carboxylate reductase 2 2
cDNA, FLJ94136, highly similar to Homo sapiens
synaptotagmin binding, cytoplasmic RNA interacting protein
(SYNCRIP)
2
cDNA FLJ53662, highly similar to Actin, alpha skeletal muscle 2
plasmids. Capsid-DDX3X interaction was verified by performing
immunoprecipitation (IP) of capsid and western blot analysis
for DDX3X. DDX3X was found to co-immunoprecipitate with
capsid (Figure 1B). We next performed IP with either DDX3X
antibody or capsid antibody in cell lysates prepared from Huh-
7 cells infected with 5 MOI of DENV2. We observed co-IP of
capsid and DDX3X respectively demonstrating the interaction of
dengue capsid and DDX3X in the context of dengue infection
(Figures 1C,D). The interaction of DDX3X with capsid was
unaffected by pre-treatment of lysates with RNAse suggesting
that the interaction was not bridged by RNA (Figure S2).
Earlier studies with Hepatitis C virus core protein have shown
that the N-terminal region of the core protein is sufficient
for interaction with DDX3X (Owsianka and Patel, 1999). We
generated truncated versions of DENV2 capsid based on the
alpha-helical regions (Ma et al., 2004). However, we were able to
detect expression of only the capsid construct lacking the first α-
helix (α2-4-capsid) (Figure S3). Next, we transfected either full-
length or α2-4-capsid constructs into HEK293T cells and verified
co-IP of endogenous DDX3X with capsid antibody. As expected,
DDX3X pull-down was observed with full-length capsid and the
same was drastically reduced with α2-4-capsid suggesting that
the N-terminal 45 amino acids of DENV capsid is required for
interaction with DDX3X (Figure 2A). To further identify the
capsid-interacting region in DDX3X, we generated HA-tagged
DDX3X constructs with C-terminal deletions (DDX3X-1351-
661, DDX3X-1385-661), N-terminal deletion (DDX3X-11-381)
and a double deletion mutant (DDX3X-11-222, 1351-661) and
the full-length DDX3X (DDX3X-FL) (Figure 2B). We verified
the expression of these deletion constructs in HEK293T cells
and observed that the expression of DDX3X-11-381 was highest,
followed by DDX3X-1351-661. DDX3X-FL and DDX3X-1385-
661 constructs had comparable expression levels. The double
deletion mutant (DDX3X-11-222, 1351-661) had the lowest
expression compared to all other constructs (Figure 2C, i).
As we faced technical difficulties with co-immunoprecipitation
of capsid using HA antibodies from infected cells, these HA-
tagged constructs were expressed in HEK293T cells and equal
quantity of lysates (normalized to HA-DDX3X expression levels)
containing the recombinant HA-tagged proteins were incubated
with purified His-capsid by in-solution interaction method as
described in methods section. His-capsid was pulled down using
Ni-NTA and co-elution of capsid protein was observed with
all the HA-DDX3X constructs except the N-terminal deletion
mutant (DDX3X-11-381) (Figure 2C, ii). It is important to
note that pull-down of HA-tagged DDX3X was observed in
the presence of endogenous DDX3X present in the lysate
which would act as a competitor for binding to capsid protein.
Therefore, the low amounts of HA-DDX3X observed cannot
be interpreted as weak interaction. The same lysates incubated
with Ni-NTA beads alone failed to pull down any of the HA-
tagged proteins ruling out non-specific interaction with the beads
alone (Figure 2C, iii). The double deletion mutant (DDX3X-
11-222, 1351-661) was capable of co-eluting with capsid, albeit
at a lower levels relative to other constructs, and the DDX3X-
1351-661 was most efficient in interaction with capsid under
these conditions. Therefore, our data indicate that the N-terminal
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FIGURE 1 | Capsid coimmunoprecipitates with DDX3X from cell lysates. (A) In-solution interaction of purified His-tagged DENV capsid and Huh-7 lysate was followed
by pull-down of interacting proteins using Ni-NTA beads. Pull down with Huh-7 lysate alone is used as a control. (B) His-tagged DENV capsid and HA-DDX3X were
co-transfected in HEK293T cells. 24 h p.t. lysate was prepared and capsid was immunoprecipitated using DENV capsid antibody. Total lysate and immunoprecipitated
proteins were analyzed by western blots probed for capsid, HA and GAPDH. (C,D) Huh-7 cells were infected with DENV at an MOI of 5. At 24 h pi mock and
DENV-infected Huh-7 cell lysates were prepared, endogenous DDX3X (C) or DENV capsid (D) was immunoprecipitated from total lysates using DDX3X or DENV
capsid antibody respectively. Total lysate and immunoprecipitated proteins were analyzed by western blots probed for capsid and DDX3X.
domain consisting of amino acids 223-350 is theminimal domain
required for efficient interaction of DDX3X with DENV capsid.
DENV Down-Regulates DDX3X at Later
Stages of Infection
The role of DDX3X in viral infections is poorly characterized.
DDX3X has been shown to act as either a necessary factor or
an inhibitor in viral replication (Yedavalli et al., 2004; Chang
et al., 2006; Kalverda et al., 2009; Angus et al., 2010; Oshiumi
et al., 2010a; Garbelli et al., 2011a; Chahar et al., 2013; Lai et al.,
2013; Li et al., 2014, 2015; Pène et al., 2015). We analyzed the
effect of DENV infection on DDX3X protein levels in different
cell lines. A549 and Huh-7 cells were infected with DENV and
DDX3X levels were monitored by western blot analysis at 24
and 48 h pi. We observed a significant decrease in DDX3X
protein levels at 48 h pi in both the cell lines (Figures 3A–C).
We further verified if the reduction in the DDX3X protein levels
is reflected at the mRNA levels by measuring the transcripts
of DDX3X in dengue infection in Huh-7 cells. We observed a
significant reduction in the mRNA levels of DDX3X at 48 h pi
suggesting that DENV infection suppresses the expression of
DDX3X at mRNA level at later stages of infection (Figure 3D).
The reduction in DDX3X levels were further confirmed by
immunofluorescence analysis where DDX3X levels were lower in
infected cells at 48 h pi however there was no significant change
in distribution of DDX3X in infected cells and we observed no
co-localization with viral envelope (Figure S4). Colocalization
studies with viral capsid could not be performed as both DDX3X
and capsid antibodies were raised in rabbit.
DDX3X Inhibits DENV Replication
To further assess the role of DDX3X in DENV infection, we
performed the knock-down of DDX3X expression using siRNAs
in Huh-7 cells. Cells were treated with either DDX3X smart-
pool siRNAs or a non-targeting control (NTC) siRNA followed
by infection with DENV2. Supernatants were collected at 24 h
pi for plaque assay and total RNA was isolated from cells for
RT-PCR. Knockdown of DDX3X was confirmed by western blot
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FIGURE 2 | Co-immunoprecipitation and pull-down of recombinant capsid and DDX3X. (A) Full length His-capsid and α2-4 His-capsid were transfected in HEK293T
cells and lysates were prepared 24 h p.t. Lysates were used for IP with capsid antibody and blots were probed for capsid, DDX3X and GAPDH. (B) Map of the
(Continued)
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FIGURE 2 | HA-DDX3X deletion constructs. (C) Total lysates were prepared from HEK293T cells transfected with HA-DDX3X-FL and HA-DDX3X deletion constructs
at 24 h p.t. Purified His-capsid was added to the lysate for in-solution interaction and protein complexes were pulled down by Ni-NTA beads. Lysates incubated with
Ni-NTA beads only were used as negative control. The beads were washed, boiled in Laemmli buffer and loaded on SDS PAGE and probed for HA-tag, capsid and
Actin. In the first lane of blot (i) purified His-capsid was loaded as a positive control for capsid antibody. Total lysate of HEK293T cells transfected with
HA-DDX3X-1351-661 and total lysate of HEK293T cells transfected with HA-DDX3X-1351-661 and infected with DENV was loaded as positive controls respectively
in blots (ii) and (iii) for HA, capsid and actin antibodies.
FIGURE 3 | DENV down-regulates DDX3X at later stages of infection. A549 and Huh-7 cells were infected with DENV at 3 MOI. Cells were collected at 24 and 48 h pi
for either lysate preparation or for total RNA isolation. (A) Cell lysates were used for western blot analysis for DDX3X, GAPDH and capsid in both cell lines. (B).
Densitometry quantitation of the blots for A549 cells (n = 4). (C) Quantitation of blots for Huh-7 cells (n = 4). (D) Total RNA was used to estimate mRNA levels of
DDX3X by real-time PCR from 3 independent experiments performed in triplicates (n = 9). Data is represented as mean ±SEM. *P < 0.05 and ***P < 0.0005, ns =
not significant.
analysis with cell lysates (Figure 4A). There was about three-
fold increase in viral titers in the supernatants of cells where
DDX3X expression was knocked down as compared to the NTC
(Figure 4B). We further confirmed this observation by using
single siRNAs (siDDX3X-1 and siDDX3X-2) to knock-down
DDX3X in order to rule out off-target effects of smart-pool
siRNAs (siDDX3X). A similar increase in viral titers was observed
when individual siRNAs were used to knock-down DDX3X
expression (Figure 4C) further confirming that the increase in
viral titers is not due to the off-target effect of smart pool
siRNAs. The increase in viral titers due to DDX3X knock-down
suggested enhanced viral entry, replication or egress due to
reduced DDX3X expression. To further identify the stage of
DENV life cycle that DDX3X may be involved in, we performed
time-course experiments and evaluated the DENV genome levels
at 1, 12, 24, and 48 h pi in Huh-7 cells transfected with NTC or
DDX3X siRNAs. We observed around 1.4 fold increase in DENV
RNA levels at 24 h pi which further increased to 2.5-fold at 48 h pi
in DDX3X knock-down cells as compared to NTC (Figure 4D).
The viral RNA levels at 1 h pi did not show any difference
between si-DDX3X and NTC samples indicating that the effect
observed is not due to enhanced viral entry. The knock-down of
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FIGURE 4 | Knockdown of DDX3X enhances DENV infection. Knockdown of DDX3X was performed in Huh-7 cells using smartpool siRNAs (si-DDX3X) and at 48 h p.t
cells were infected with DENV at 1 MOI. Viral titres and RNA levels were verified at 24 h p.i. (A) Western blot analysis to verify knockdown of DDX3X. β-actin level is
shown as a loading control and DENV-NS3 antibody was used to detect infection levels. (B) Viral titers were estimated by plaque assay. (C) DDX3X expression was
knocked down by a single siRNA (si-DDX3X-1 or si-DDX3X-2) or using smartpool siRNAs (si-DDX3X) in Huh-7 cells and 48 h p.t. cells were infected with DENV at 1
MOI. Upper panel shows the western blot for knockdown efficiency. Lower panel shows viral titres estimated at 24 h pi. Figure is representative of three independent
experiments performed with triplicate samples (D) Kinetics of infection in Huh-7 cells after DDX3X knockdown. Cells were collected at 1, 12, 24, and 48 h pi and
DENV genome levels were estimated by real-time PCR. Data from two independent experiments performed with triplicate samples (n = 6) is represented as mean ±
SEM. (E) Knockdown of DDX3X was performed in Huh-7 cells using smartpool siRNAs (si-DDX3X) and single siRNA (si-DDX3X-1) and cell proliferation was assessed
as described in the methods section at 48 h post-transfection. *P < 0.05 and **P < 0.005.
DDX3X by siRNAs did not affect cell proliferation (Figure 4E).
Similar results were obtained with A549 cells where knock-down
of DDX3X led to enhanced DENV RNA levels and viral titers
as compared to NTC (Figures S5A–D). These results clearly
suggest that DDX3X may exert its antiviral effect at a post-entry
stage which may have a direct or indirect effect on DENV RNA
replication.
As silencing DDX3X expression led to increased DENV titers,
we speculated that overexpression of DDX3X would lead to
an enhanced antiviral state and inhibit DENV infection. We
tested this by transfecting HA-DDX3X plasmid and its vector in
HEK293T cells. At 24 h p.t, cells were fixed and stained with HA
and DENV envelope antibody. Viral titers in the supernatants
were measured by plaque assay. DENV infection was absent in
cells expressing HA-DDX3X while un-transfected cells showed
DENV positivity (Figure 5A). HA-DDX3X overexpression led to
a 50% reduction in DENV infection (Figure 5B), which further
correlated with a five-fold reduction in viral titers (Figure 5C).
Similar results were obtained in Huh-7 cells transfected with HA-
DDX3X where we observed 50% reduction in both viral titers
and DENV RNA levels under DDX3X overexpression conditions
(Figures S6A,B). Our results with DDX3X knock-down and
overexpression suggest an antiviral role for DDX3X in DENV
infection.
The N-Terminal 1-350 aa Domain of DDX3X
Is Required for the Antiviral Activity
DDX3X performs multiple functions due to its multiple
functional domains, which include the RNA helicase, ATPase
and RNA binding activities (Garbelli et al., 2011b; Soto-Rifo
and Ohlmann, 2013; Valiente-Echeverría et al., 2015). To further
verify the domain required for the antiviral activity of DDX3X
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FIGURE 5 | DDX3X overexpression suppresses dengue infection. (A) HA-DDX3X plasmid or the vector was transfected in HEK293T cells. 24 h p.t. cells were infected
with DENV at 5 MOI. Cells were fixed and stained for dengue envelope and HA at 24 h pi. (B) Percentage of infected cells was counted in ten fields each in three
independent experiments (∼3000 cells were counted) (C) Viral titres were estimated by plaque assay at 24 h pi. Data is represented as mean ± SEM. ***P < 0.0005.
by flow cytometry we created truncations in the DDX3X protein
by generating the following GFP-tagged constructs: full length
DDX3X (DDX3X-FL) and constructs lacking the c-terminal
domains (DDX3X-1351-661, DDX3X-1385-661). The plasmids
were transfected in HEK293T and at 24 h post-transfection,
the cells were infected with DENV at 5 MOI and at 24 h
pi cells were fixed and DENV infection in GFPhigh cells was
assessed by staining with DENV-E antibody conjugated with
allophycocyanin (APC) using flow cytometry (Figure S7). Cells
expressing GFP-tagged-DDX3X-FL showed a 50% decrease in
infection as compared to the GFP-vector alone (Figures 6A,B).
The antiviral activity of GFP-DDX3X was less as compared to
HA-DDX3X (Figure 4) most probably due to differences in the
expression levels of these constructs and also due to altered
sub-cellular localization of GFP-DDX3X most likely due to the
larger GFP-tag (Figure S8). Cells expressing DDX3X-1351-661
(34.6%) and DDX3X-1385-661 (31.2%) also showed a significant
inhibition of DENV infection (Figures 6C,D), although the
effect was slightly less than full-length DDX3X (Figure 6E).
Overexpression of any of these constructs had no effect on cell
viability (Figures S9A–D). We also generated the N-terminal
deletion construct GFP-DDX3X-11-381 which was found to
localize to the nucleus suggesting that the c-terminal region of
the protein is necessary for proper localization of the protein.
Therefore, although this construct was useful in in vitro assays
to demonstrate binding to capsid, the same was not appropriate
for performing cellular interactions and antiviral functions due
to altered localization. As the loss of aa 351-661 retained the
antiviral activity, these results indicate that the N-terminal region
of DDX3X, 1-350 aa, which contains the motifs Q, I, Ia, Ib, and
DEAD box is sufficient for the antiviral functions of DDX3X.
Such an effect may be expected as this region contains conserved
motifs that are involved in ATP and RNA binding (Bol et al.,
2015).
In a previous report, the antiviral function of DDX3X was
attributed to its role in the induction of interferon-β as knock-
down of DDX3X led to suppression of IFN-β production and
increase in DENV titers (Li et al., 2015). To confirm this under
our infection conditions, we measured the mRNA levels of IFN-
β in cells with si-DDX3X transfection. We did not observe any
significant difference in the basal levels of IFN-β transcript when
DDX3X expression was suppressed in Huh-7 cells. Moreover,
induction of IFN-β was not impaired upon dengue infection
in both NTC and si-DDX3X cells indicating that DDX3X was
not essential for induction of IFN-β in DENV infection or the
residual levels of DDX3X present in knock-down cells may
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FIGURE 6 | Domain mapping of DDX3X antiviral activity. GFP tagged-DDX3X plasmids were transfected in HEK-293T cells and at 24 h p.t, cells were infected with
DENV at 5 MOI. Cells were fixed and stained at 24 h pi with dengue envelope antibody. Cells were acquired in FACS and GFP signal was used to identify transfected
cells. (A–D) Representative plots for percent DENV positive in GFPhigh cells for each GFP-DDX3X construct. (E) Quantitation of DENV positivity in GFPhigh for all
GFP-DDX3X constructs. The experiment was performed twice with two replicates in each. Data is represented as mean ±SEM. *P < 0.05.
be sufficient for IFN-β production (Figure S10). These results
indicate that the antiviral effect of DDX3X in dengue infection
is independent of interferon induction pathways.
DISCUSSION
Previous studies have shown the role of DDX3X in viral
infections and in innate immune signaling (Yedavalli et al., 2004;
Chang et al., 2006; Kalverda et al., 2009; Angus et al., 2010;
Oshiumi et al., 2010a; Garbelli et al., 2011a; Chahar et al., 2013;
Lai et al., 2013; Li et al., 2014, 2015; Pène et al., 2015). We
have identified DDX3X as a DENV capsid-interacting protein
and further confirm its anti-viral role in DENV infection. We
show that the N-terminal 45 amino acids including the α-
helix-1 of DENV-C was essential for interaction with DDX3X.
Interestingly, HCV core protein was also shown to interact with
DDX3X via its N-terminal domain and abrogation of DDX3X
and HCV core interaction by mutagenesis had no effect on
viral replication and infectious virus production indicating that
HCV core and DDX3X interaction may have an indirect effect
on host functions (Angus et al., 2010). In addition, DDX3X
was also identified as a host factor in HCV infection by a
genome-wide genetic screening and was shown to be involved
at late stages of viral replication (Li et al., 2009). DDX3X was
shown to sequester HCV RNA to lipid droplets and this was
proposed to be an immune evasion strategy (Ariumi et al.,
2011). Although HCV is a member of the family Flaviviridae,
it belongs to a different genus (Hepacivirus) and has a different
mode of RNA replication. The HCV core was shown to bind
c-terminal domain of DDX3X and knock-down of DDX3X
led to reduction in viral replication which is contrary to our
observations with dengue virus. Therefore, these viruses may
utilize DDX3X in different ways. The role of DDX3X in HIV
replication is one of the well-characterized examples. DDX3X
along with its binding partner Chromosome Maintenance-1
(CRM-1) was involved in the nuclear export of HIV RNA by Rev-
Rev Response Element (RRE) complex (Yedavalli et al., 2004).
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In addition, DDX3X was also shown to promote translation
initiation of HIV mRNA (Soto-Rifo et al., 2013). DDX3X been
shown to be required for viral replication in the case of murine
norovirus (Yedavalli et al., 2004; Angus et al., 2010; Vashist et al.,
2012). DDX3X has also been shown to act as an antiviral protein
owing to its involvement in the upstream events leading to IFN-
β induction (Schröder et al., 2008; Soulat et al., 2008; Oshiumi
et al., 2010b). Therefore, in contrast to its proviral role in the
case of HCV and HIV, DDX3X has been shown to play an
antiviral role in vaccinia virus, hepatitis B virus and vesicular
stomatitis virus infections (Oshiumi et al., 2010b; Wang and
Ryu, 2010; Schroder, 2011). In the case of flaviviruses, DDX3X
and other components of P bodies and stress granules were
shown to be redistributed to viral replication compartments in
West Nile virus infected cells although the relevance of this
finding is yet to be determined (Chahar et al., 2013). In the
case of Japanese encephalitis virus, DDX3X knock-down led to
inhibition of viral titers, however, overexpression of DDX3X or
any of the mutants under knock-down conditions suggested that
the helicase activity of DDX3X is involved in JEV replication in
BHK-21 cells. DDX3X was shown to play a role in translation
of JEV proteins by interacting with viral non-structural proteins
and 5′ and 3′ untranslated regions of viral RNA (Li et al.,
2014). As JEV is a neurotropic virus, these observations need
further validation in cells of central nervous system or at least
in immortalized human cell lines. In a siRNA screening to
identify DEAD-box family genes involved in DENV infection,
Li et. al., identified DDX3X and DDX50 as the two DEAD-
box family members which, when suppressed by siRNAs, led
to significant upregulation of viral replication and DDX25 and
DDX26 knock-down led to downregulation of DENV replication
(Li et al., 2015). We have made a similar observation in our
study where knock-down of DDX3X led to increase in viral
titers and intracellular viral RNA levels without affecting viral
entry and overexpression of DDX3X led to inhibition of virus
replication. We were not successful in our attempts to purify
DDX3X protein in prokaryotic expression system, therefore, a
direct binding between DDX3X and dengue capsid could not
be demonstrated. Nevertheless, we show by indirect methods
that the motifs within the N-terminal region are important
for the anti-viral role of DDX3X, since C-terminal deletions
up to 350 a.a retained anti-viral functions of DDX3X. The N-
terminal region of the protein consists of motifs Q, I, Ia, Ib,
and DEAD box, which are involved in ATP and RNA binding
(Cordin et al., 2006; Henn et al., 2012; Bol et al., 2015), and thus
may be important in anti-viral response in the cell. This clearly
demonstrates the antiviral function of DDX3X in cells infected
with dengue virus and we show downregulation of DDX3X
at later stages of DENV infection which could be an immune
evasion strategy.
Huh-7 cells are deficient in TLR3-mediated pathway and
rely on RIG-I pathway for induction of type I interferons
(Li et al., 2005). We observed that DDX3X knock-down
did not hamper the induction of IFN-β suggesting that
reduction in type I interferons is not a reason for higher
viral titers observed in these cells. We speculate that DDX3X
may mediate anti-viral effects independent of IFN-β response
by other stress response pathways. We have shown recently
that drugs that induced autophagy acted as potent inhibitors
of DENV replication (Medigeshi et al., 2016). Therefore, it
would be interesting to investigate the role of DDX3X in
autophagy. DDX3X is a phosphorylation target of TANK-
binding kinase-1 (TBK-1), which has been shown to be a
crucial bridge between innate immune responses and autophagy
(Weidberg and Elazar, 2011; Pilli et al., 2012). It is possible
that DDX3X may regulate autophagy through some of its
interacting partners such as TBK-1, which warrants further
investigation.
Recent reports have suggested a prominent role for DDX3X in
stress granule formation and many viruses have been shown to
hijack DDX3X to modulate/utilize this function (Chahar et al.,
2013). We have not investigated the role of stress granules in
our study. However, it should be noted that the list of proteins
identified by mass spectrometry included ribonucleoproteins
(RNPs) hnRNPQ, hnRNPA0, hnRNPA1 and hnRNPU of which
all except hnRNPA0 have been shown to be components
of stress granules and P bodies (Guil et al., 2006; Gallois-
Montbrun et al., 2007; Quaresma et al., 2009). Recent reports
have demonstrated the role of ribonucleoproteins in dengue
virus replication as NS-1 and capsid-interacting partners (Chang
et al., 2001; Brunetti et al., 2015; Dechtawewat et al., 2015;
Diwaker et al., 2016). Further studies are required to understand
if the hnRNPs identified in our study also play a similar role
in DENV infection. It is plausible that DDX3X is part of a
multifunctional protein complex involving RNPs, which interact
with DENV capsid and future studies may focus on probing
this further. The other capsid-interacting proteins identified in
our study are various 60S and 40S ribosomal proteins which
have been shown to be involved in ribosomal biogenesis. A
putative protein which is highly similar to 60 kDa heat shock
protein was also identified in this study. Interestingly, HSP60
has been shown to be involved in viral infections such as
rotavirus, hepatitis B virus and dengue virus by eithermodulating
apoptotic pathways or immune responses (Tanaka et al., 2004;
Padwad et al., 2009; Chattopadhyay et al., 2017). In addition,
as in this study, previous reports have also identified histone
proteins as binding partners of DENV capsid further indicating
that the list of proteins that we have identified are relevant for
DENV biology (Colpitts et al., 2011). The relevance of other
identified proteins such as the mitochondrial protein Pyrroline-
5-carboxylate reductase 2 which catalyzes the conversion of
pyrroline-5-carboxylate to proline, and other putative proteins
similar to synaptotagmin binding, cytoplasmic RNA interacting
protein (SYNCRIP) and skeletal muscle α-actin remains to be
explored.
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Figure S1 | Purification of His-capsid protein. (A) Purification of the His-capsid
protein as described in methodology using Ni-NTA beads. (B) Western blot
showing purified His-capsid probed using anti-His antibody.
Figure S2 | Interaction between capsid and DDX3X is not mediated via RNA.
Huh-7 cells were infected with DENV at an MOI of 5. At 24 h pi mock and
DENV-infected Huh-7 cell lysates were prepared and treated with RNAse prior to
immunoprecipitation. DDX3X was immunoprecipitated from total lysates
(untreated) and RNAse-treated lysates using DDX3X antibody at 4◦C. Total lysate
and immunoprecipitated proteins were detected by western blots.
Figure S3 | Deletion constructs of capsid. (A) Graphical representation of
His-capsid deletion constructs. (B) HEK293T cells were transfected with plasmids
encoding various capsid constructs. Total lysates were prepared at 24 h p.t. and
expression of recombinant His-tagged proteins were analyzed by western blotting
with capsid antibody. GAPDH levels are shown as loading controls.
Figure S4 | DENV infection downregulates DDX3X in Huh-7 cells at later stages of
infection. (A) Huh-7 cells were infected at 1 MOI and fixed at 24 and 48 h pi. Cells
were stained for DDX3X (red), dengue envelope (green) and nuclei with DAPI
(blue). (B) The fluorescence intensity of DDX3X staining was quantitated using
Fluoview software. Quantitation of DDX3X fluorescence intensity (AU) at 24 and
48 h pi. (n = 15) ∗∗∗P < 0.0005.
Figure S5 | DDX3X downregulation enhances DENV infection in A549 cells. (A)
Cells were transfected with si-NTC or si-DDX3X and at 48 h p.t. knock-down
efficiency was measured by real-time PCR from total RNA. (B) Cells transfected
with si-NTC or si-DDX3X were infected with DENV at 3 MOI at 48 h p.t. Viral titres
were estimated at 24 h pi by plaque assay and viral genome levels were analyzed
by real-time and normalized to GAPDH (C) Data represents three independent
experiments performed with triplicates samples (n = 9). (D) Viral entry was
assessed in DDX3X knockdown cells. Cells were collected after 1 h of virus
adsorption and viral genome levels was analyzed by real-time PCR. Data
presented are from two independent experiments performed with three replicates
each (n = 6). Data is represented as mean ±SEM. ∗∗P < 0.005 and
∗∗∗P < 0.0005, ns = not significant.
Figure S6 | Overexpression of HA-DDX3X in Huh-7 cells inhibits virus replication.
HA-DDX3X was transfected in Huh-7 cells, and at 24 h p.t, cells were infected with
DENV at 3 MOI and viral titers were measured by plaque assay at 24 h pi (A)
DENV viral genome levels were estimated by real-time PCR. Data is from three
independent experiments performed in triplicates (n = 9). (B) Data is represented
as mean ± SEM. ∗∗P < 0.005.
Figure S7 | Gating strategy for dengue infection in GFP-DDX3X transfected cells.
HEK293T cells transfected with GFP-DDX3X constructs were infected with DENV2
at 5 MOI at 24 h pt. At 24 h pi, cells were fixed and stained with APC-conjugated
anti-DENV envelope antibody. Single cell population was gated in FSC-H vs.
FSC-A plot and SSC-A vs. FSC-A plot. Live cells were gated for analysis.
Dengue-E positive cells were gated in total GFP, GFPlow and GFPhigh respectively.
Figure S8 | Overexpression of HA-DDX3X and GFP-DDX3X. HA- or GFP-tagged
DDX3X constructs were transfected in HEK-293T cells and at 48 h p.t, cells were
fixed and HA-DDX3X transfection samples were stained with HA antibody followed
by secondary antibody conjugated with Alexa-488. Nuclei was stained with DAPI.
Figure S9 | Overexpression of DDX3X plasmids does not affect cell viability.
GFP-tagged DDX3X constructs were transfected in HEK-293T cells and at 24 h
p.t, cells were infected with DENV at 5 MOI. (A–D) The fixable live-dead viability
stain (BD EF-780) was added at 1:1000 dilution and incubated at RT for 10min
and then washed with FACS buffer. Cells were processed by flow cytometry.
Figure S10 | IFN-β levels in Huh-7 in DDX3X knockdown and DENV infection.
siRNA knockdown of DDX3X was done in Huh-7. Forty-eight hour p.t, cells were
either mock or DENV infected at 10 MOI. Twenty-four hour p.i the IFN-β mRNA
levels were assessed by real-time PCR. Data is represented as mean ± SEM.
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